OCUL OCULAR THERAPEUTIX
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 17 analyst firms say about OCULAR THERAPEUTIX: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
17 rated views · 18 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #39 in the index87
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8058
Recent analyst activity · last 90 days
Our tracked history has 14 reports on OCUL from 10 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 6 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Colleen Kusy | Buy | 18 Jun 2026 | 30.00 USD |
| Baird | Jack K Allen | Buy | 17 Aug 2026 | 30.00 USD |
| Chardan Capital Markets | Andreas Argyrides | Buy | 2 Oct 2026 | 23.00 USD |
| Citigroup | Unnamed analyst | Buy | 17 Feb 2026 | — |
| Citizens JMP | Jonathan Wolleben | Buy | 24 Mar 2026 | 34.00 USD |
| Clear Street | Unnamed analyst | Buy | 3 Mar 2026 | 28.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 4 Aug 2026 | 28.00 USD |
| H.C. Wainwright | Yi Chen | Buy | 20 Oct 2026 | 25.00 USD |
| Jefferies | Unnamed analyst | Buy | 17 Feb 2026 | — |
| Needham | Serge Belanger | Buy | 19 Oct 2026 | 18.00 USD |
| Piper Sandler | Biren Amin | Buy | 12 Oct 2026 | 31.00 USD |
| Raymond James | Sean Mccutcheon | Buy | 3 Aug 2026 | — |
| RBC Capital Markets | Lisa Walter | Buy | 29 Sep 2026 | 30.00 USD |
| TD Cowen | Tara Bancroft | Buy | 15 Jun 2026 | 20.00 USD |
| UBS | Alice Nettleton | Buy | 11 Oct 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Lachlan Hanbury-Brown | Buy | 13 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 12 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.